Senior Director, Prostate Cancer Clinical Development

Bristol-Myers Squibb Co; Lawrence Township (NJ); Remote; USD 307,000 - 372,000; Full time

Benefits offered by this job

Flexible Time Off

11 paid company holidays

Comprehensive benefits

Job summary

RayzeBio, a Bristol Myers Squibb affiliate, seeks a Senior Director of Clinical Development for Prostate Cancer. You will design and lead clinical programs from IND to Phase 3, guide regulatory interactions, and build a robust, cross-functional team across translational and clinical science.

You’ll partner with research and translational medicine to inform pipeline assets, participate in BD due diligence, and drive strategy with oncology leadership. Light travel ~30% expected.

Qualifications

• MD, PhD, PharmD or equivalent ideally with sub-specialty training in oncology and extensive oncology development experience.
• Experience leading clinical programs from IND to Phase 3 and NDA/MAA preparation.
• Experience collaborating with investigators, CROs, and regulatory authorities globally.

Responsibilities

• Lead the clinical development strategy for prostate cancer assets from IND through Phase 3.
• Build and mentor the clinical team and cross-functional study teams.
• Oversee regulatory submissions and interactions; manage budgets and milestones.
• Drive BD/due diligence input to expand RayzeBio’s portfolio.
• Travel approximately 30% as needed.

Skills

Clinical leadership

Regulatory interactions

Cross-functional leadership

Strategic thinking

Communication skills

Education

MD/PhD/PharmD or equivalent

Job description

RayzeBio, a Bristol Myers Squibb affiliate, seeks a Senior Director of Clinical Development for Prostate Cancer. You will design and lead clinical programs from IND to Phase 3, guide regulatory interactions, and build a robust, cross-functional team across translational and clinical science.

You’ll partner with research and translational medicine to inform pipeline assets, participate in BD due diligence, and drive strategy with oncology leadership. Light travel ~30% expected.